Your search returned 2 results.

Results
	1.	Discovery and preclinical profile of Saxagliptin (BMS-477118): a highly potent, long-acting, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes. [electronic resource] by Augeri, David J Robl, Jeffrey A Betebenner, David A Magnin, David R Khanna, Ashish Robertson, James G Wang, Aiying Simpkins, Ligaya M Taunk, Prakash Huang, Qi Han, Song-Ping Abboa-Offei, Benoni Cap, Michael Xin, Li Tao, Li Tozzo, Effie Welzel, Gustav E Egan, Donald M Marcinkeviciene, Jovita Chang, Shu Y Biller, Scott A Kirby, Mark S Parker, Rex A Hamann, Lawrence G Producer: 20050823 In: Journal of medicinal chemistry vol. 48 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Synthesis of novel potent dipeptidyl peptidase IV inhibitors with enhanced chemical stability: interplay between the N-terminal amino acid alkyl side chain and the cyclopropyl group of alpha-aminoacyl-l-cis-4,5-methanoprolinenitrile-based inhibitors. [electronic resource] by Magnin, David R Robl, Jeffrey A Sulsky, Richard B Augeri, David J Huang, Yanting Simpkins, Ligaya M Taunk, Prakash C Betebenner, David A Robertson, James G Abboa-Offei, Benoni E Wang, Aiying Cap, Michael Xin, Li Tao, Li Sitkoff, Doree F Malley, Mary F Gougoutas, Jack Z Khanna, Ashish Huang, Qi Han, Song-Ping Parker, Rex A Hamann, Lawrence G Producer: 20040616 In: Journal of medicinal chemistry vol. 47 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)